A clinical trial to test the safety and efficacy of dose escalation of non-alpha IL-2 mutein. A product obtained at the Center for Molecular Immunology. It is being carried out at the Hermanos Ameijeiras Clinical Surgical Hospital in Havana.
According to Oncology specialist Vilma Fleites. This drug is applied to patients with advanced solid tumors in progression. Who have been subjected to other treatments.
The research has completed the first phase and is in a second stage of studies. With positive results in terms of the effectiveness of anti-tumor therapy, she said.
She stressed that these trials are a fundamental pillar for clinical oncologists. As new care protocols are discovered and applied that allow the management of clinical oncology in a clinical way. A palliative care of patients, without other options for oncological therapies, she said.
Today, in this service of that institution, several clinical trials are being carried out. In the effort to find new effective drugs against various variants of cancer. Which is the second cause of death in Cuba.
With information from Cuban News Agency
Translated by Aliani Rojas Fernández
Latest posts by Radio Angulo (see all)
- Housing Construction in Antilla Benefits Vulnerable Families - 29 de April de 2025
- Díaz-Canel Urges People to Show Unity This May 1st - 29 de April de 2025
- Death toll rises from explosion at southern Iranian port - 28 de April de 2025